Phenobarbital Mechanism of Action
Phenobarbital primarily acts by enhancing GABAergic inhibition through direct action on GABA_A receptors, prolonging chloride channel opening and producing dose-dependent CNS depression from sedation to deep coma. 1
Primary Mechanism: GABA_A Receptor Modulation
Phenobarbital functions as a positive allosteric modulator of GABA_A receptors, the main inhibitory neurotransmitter system in the brain 2, 3. The drug works through several specific actions:
- Prolongs chloride channel opening: Phenobarbital increases the channel-opening equilibrium constant by decreasing the channel-closing rate constant approximately 8-fold while minimally affecting the channel-opening rate 4
- Direct receptor activation: At higher concentrations, phenobarbital can directly activate GABA_A receptors independent of GABA binding 2
- Binding site: The mechanism involves the second and third transmembrane domains of the β subunit, with binding likely occurring at a pocket formed by β-subunit methionine 286 and α-subunit methionine 236 2
The enhanced GABAergic inhibition results in increased chloride anion influx into neurons, causing hyperpolarization and reduced neuronal excitability 3.
Secondary Mechanisms
Beyond GABA_A receptor modulation, phenobarbital exhibits additional pharmacological actions:
- Glutamate antagonism: Blocks AMPA/kainate receptors and inhibits glutamate release through effects on P/Q-type high-voltage activated calcium channels 2, 3
- Selective anticonvulsant activity: Phenobarbital possesses anticonvulsant effects independent of sedation, limiting seizure spread and raising the seizure threshold in generalized tonic-clonic epilepsy 1
Clinical Effects and Pharmacodynamics
The drug produces dose-dependent CNS effects 1:
- Therapeutic doses: Sedation, decreased motor activity, altered cerebellar function
- Anticonvulsant doses: Seizure control without proportional sedation (distinguishing it from other barbiturates like pentobarbital)
- High doses: Deep coma, respiratory depression via direct medullary respiratory center suppression, and potential cardiovascular depression through medullary vasomotor center effects 5
Critical distinction: While tolerance develops to sedative-hypnotic effects through CYP-mediated auto-induction, tolerance to lethal respiratory depression does not occur—meaning chronic users tolerate higher doses but not higher serum concentrations before toxicity 5.
Respiratory and Cardiovascular Effects
Phenobarbital acts as a respiratory depressant by diminishing the medullary respiratory center's sensitivity to carbon dioxide 1. At hypnotic doses, respiratory depression resembles physiologic sleep with minimal cardiovascular impact. However, severe toxicity can produce profound respiratory failure and hypotension 5.
Hepatic Enzyme Induction
Phenobarbital is a well-known inducer of hepatic cytochrome P450 enzymes, increasing metabolic clearance of CYP substrates and exhibiting auto-induction that contributes to tolerance development 5.